WHO certified Belize as malaria-free
On Jun. 21, 2023, the World Health Organization (WHO) announced that it had certified Belize as malaria-free, following…
-
-
WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
On May 31, 2023, the World Health Organization (WHO) announced it had assigned simple, easy to say and…
-
WHO reported Avian influenza A(H5N1) in United Kingdom of Great Britain and Northern Ireland
On May 30, 2023, the United Kingdom of Great Britain and Northern Ireland reported to the World Health…
-
WHO declared end to mpox public health emergency
On May 11, 2023, the World Health Organization announced it was ending a 10-month-long global health emergency for…
-
152 million babies born preterm in the 2010-20 decade
On May 9, 2023, United Nations agencies and partners reported that an estimated 13.4 million babies were born…
-
World Health Organization ended its declaration of COVID-19 as a global health emergency
On May 5, 2023, the World Health Organization (WHO) ended its declaration of COVID-19 as a global health…
-
World Health Organization reported enterovirus infections in France
On May 5, 2023, France reported nine cases of severe neonatal sepsis associated with hepatic impairment and multi-organ failure…
-
Additional cases of Marburg virus disease reported in Equatorial Guinea
On Apr. 17, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
-
FAO and WHO released report identifying food safety hazards of cell-based food
On Apr. 6, 2023, the Food and Agriculture Organization (FAO), in collaboration with the World Health Organization (WHO),…
-
Biotechnology | Diagnostics | Disease | Vaccine | WHO
WHO certified Azerbaijan and Tajikistan as malaria-free
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Circulating vaccine-derived poliovirus type 2 (cVDPV2) reported in Indonesia
On Mar. 17, 2023, the Indonesia Ministry of Health notified the World Health Organization (WHO) of the detection…
-
Avian Influenza A (H5N1) reported in Cambodia
On Feb. 26, 2023, the Cambodia International Health Regulations (IHR) National Focal Point (NFP) reported one confirmed case…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics | WHO | Women's Health
WHO launched new roadmap on breast cancer
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
-
United Nations reported that a child or youth died once every 4.4 seconds in 2021
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
-
Study reported major reservoir of resistance in wastewater of Southeast Asia, Western Pacific
On Jan. 1, 2023, a study published in the Lancet reported that concentrations of antibiotic residues found in…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Circulating vaccine-derived poliovirus type 2 (cVDPV2) reported in Indonesia
On Nov. 12, 2022, the World Health Organization (WHO) issued a Disease Outbreak News (DON) on the circulating…
-
Oxford Ebola vaccine manufactured and shipped in record time by Serum Institute of India
On Dec. 15, 2022, the University of Oxford’s Ebola vaccine candidate has been shipped to Uganda, just 80…
-
Ebola trial candidate vaccines arrived in Uganda in record 79 days after outbreak declared
On Dec. 9, 2022, the World Health Organization (WHO) announced that the first doses of one of the…
-
Biotechnology | COVID-19 | Therapeutics | Vaccine | WHO
Novavax Nuvaxovid COVID-19 vaccine approved in Canada for use as a primary series in adolescents
On Dec. 7, 2022, Novavax announced that Health Canada had approved a supplement to a New Drug Submission…
-
Novavax updated EUA listing for Novavax Nuvaxovid COVID-19 vaccine as pimary series in adolescents and as booster in adults
On Nov. 29, 2022, Novavax announced that the World Health Organization had issued an updated Emergency Use Listing…
-
WHO recommended new name for mpox disease
On Nov. 28, 2022, the World Health Organization (WHO) announced that following a series of consultations with global…
-
WHO to identify pathogens that could cause future outbreaks and pandemics
On Nov. 21, 2022, the WHO is launching a global scientific process to update the list of priority…
-
Zimbabwe became first in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Global leaders committed US$ 2.6 billion at World Health Summit to end polio
On Oct. 18, 2022, global leaders confirmed US$ 2.6 billion in funding toward the Global Polio Eradication Initiative’s…
-
Biotechnology | Disease | WHO
WHO launched new initiative to stop the spread of invasive malaria vector in Africa
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
-
Uganda declared Ebola virus disease outbreak
On Sept. 20, 2022, health authorities in Uganda declared an outbreak of Ebola after a case of the…
-
Democratic Republic of the Congo Ebola outbreak declared over, Uganda boosted response
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
-
WHO expanded recommendation for Veklury (Remdesivir) to patients with severe disease in update to COVID-19 guideline
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living…
-
Novavax and Serum Institute of India announced full product registration in South Africa of Novavax COVID-19 vaccine
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
-
Biotechnology | Diagnostics | Disease | Vaccine | WHO
Malaria booster vaccine showed durable high efficacy in African children, meeting WHO-specified 75% efficacy goal
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
